Hunter Shkolnik of Rheingold Valet Moves to Napoli Bern Ripka, LLP
NEW YORK, July 12, 2011 /PRNewswire/ -- After more than fifteen (15) years as a Senior Partner in the New York personal injury firm Rheingold, Valet, Rheingold, Shkolnik & McCartney, LLP, Hunter Shkolnik has joined Napoli Bern Ripka, LLP ("Napoli Bern") as a Senior Partner of the firm, which will henceforth be known as Napoli Bern Ripka Shkolnik, LLP. Paul Napoli said: "Mr. Shkolnik led the complex and mass tort litigation team at Rheingold, Valet and he has long been active nationally as a leader in Pharmaceutical and Mass Tort litigations. We expect that he will continue to do so in the future".
Mr. Shkolnik has concentrated his areas of practice to the trial of significant personal injury cases primarily in the area of drug, medical device, automobile, heavy truck and aviation related product liability and medical malpractice actions. He serves as a chairman, leader or court appointed representative on Plaintiffs' Steering Committees in various consumer class actions and drug and medical device mass tort litigations including: In re: Toyota Sudden Acceleration Litigation 10:2151: Member, Liaison Counsel Committee For Personal Injury and Wrongful Death Claimants; In re: Oral Sodium Phosphate Solution- Based Products Liability Litigation 09:2066 Co-Lead Counsel; In re: Medtronic Sprint Fidelis Lead Litigation Member, Plaintiffs' Steering Committee; In re: Kaba Simplex Locks Marketing and Sales Practices Litigation; In re: POM Wonderful LLC Marketing and Sales Practices Litigation; In re: Medtronic Implantable Cardiac Defibrillators Litigation 05:1726 Member, Plaintiffs' Steering Committee; In re: Guidant Corp Implantable Defibrillators Products Liability Litigation 05:1708, Plaintiffs' Steering Committee; In re: Nuvaring Products Liability Litigation; New Jersey Levaquin Mass Tort Litigation-Discovery Co-Chair; New Jersey Nuvaring Litigation-Liaison Counsel; Co-Liaison Counsel New Jersey Metaclopromide Mass Tort Litigation. Hunter was a member of the